Webinar: New Developments in Prostate Cancer Radioligand Therapies and How to Access Them!
October 29 @ 8:00 pm - 9:30 pm EDT
Pluvicto has established radioligand therapy (RLT) as a highly viable treatment for Prostate Cancer. But it’s just the tip of the iceberg in terms of RLT choices and when they are used.
Welcome experts Dr. Michael Hofman and Dr. Frankis Almaguel to address what’s novel and when patients can expect access. Dr. Hofman will look at new developments, and Dr. Almaguel will address clinical trials. Both will consider when RLT may come to non-metastatic men.
This free, virtual event will take place on October 29th at 8 PM EST and will be hosted by Cdr. Mike Crosby, Director of the Oncidium Foundation.
